Literature DB >> 8994745

Unsuspected vasculitis and intracranial hemorrhage following thrombolysis.

G Srinivasan1, C Boschman, S I Roth, R C Hendel.   

Abstract

Treatment with thrombolytic agents such as streptokinase or tissue plasminogen activator (TPA) is an accepted standard for the treatment of patients with acute myocardial infarction (MI). A devastating sequel of thrombolytic therapy may be the development of a hemorrhagic complication, particularly intracranial bleeding, which, although rare, is usually associated with significant neurologic sequelae or death. While various risk factors have been correlated with the development of intracranial hemorrhage following thrombolysis, a possible relationship between bleeding and a clinically unsuspected underlying vasculitis has not been previously reported. This report deals with the case of a 49-year-old man who died of multiple intracranial hemorrhages after thrombolytic therapy for acute MI and who was found at autopsy to have had polyarteritis nodosa of the coronary arteries and vasculitis of the meningeal vessels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994745      PMCID: PMC6656053          DOI: 10.1002/clc.4960200118

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

Review 1.  The Effects of the SARS-CoV-2 Virus on the Cardiovascular System and Coagulation State Leading to Cardiovascular Diseases: A Narrative Review.

Authors:  Rafiq A Bhat; Syed Maqbool; Akanksha Rathi; Syed Manzoor Ali; Yoosuf Ali Ashraf Muhammad Hussenbocus; Xiao Wentao; Yongsheng Qu; You Zhang; Yuxiao Sun; Hai-Xia Fu; Ling Yun Wang; Atul Dwivedi; Javaid Akhter Bhat; Raja Saqib Iqbal; Md Monowarul Islam; Abhishek Tibrewal; Chuanyu Gao
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

Review 2.  Intravenous thrombolysis in SLE-related stroke: a case report and literature review.

Authors:  Xiaodong Chen; Gelin Xu
Journal:  Neurol Sci       Date:  2017-11-07       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.